Clinical Trials Browser

Terminated × Leukemia × Azacitidine × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Primary Myelofibrosis

Clinical Trials

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes

A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)

Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)